What it is Active Ingredient : LCarnitine (in many places called "levocarnitine") an amino acidderivative naturally present in the body
Also see news on IFFs new heart health claim for soy protein in Australia and New Zealand, plus a new study on AB-BIOTICS and Kaneka Probiotics postbiotic for skin elasticity in women
Diabetes and endocrine disorders (hyperthyroidism/hypothyroidism) as risk factors for atrial fibrillation
Rethinking the Therapy Algorithm Mar 19, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,741 views Managing type 2 diabetes today can feel like solving a moving puzzle
So with that said, I think in the beginning people thought, "This is a diabetes drug that people are now taking for weight loss," but that's not actually true anymore
In 2021, the FDA approved a third semaglutide formulation, Wegovy, for chronic weight management for those with obesity or overweight and at least one weight-related condition